Edwards Lifesciences Corporation Deferred Income Tax Assets, Net
Edwards Lifesciences Corporation (EW) had Deferred Income Tax Assets, Net of $911.80 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-04
- 2026-06-30: Deferred Income Tax Assets, Net $911.80M.
- 2026-03-31: Deferred Income Tax Assets, Net $1.10B.
- 2025-12-31: Deferred Income Tax Assets, Net $1.14B.
- 2025-09-30: Deferred Income Tax Assets, Net $1.10B.
| Period end | Deferred Income Tax Assets, Net | Deferred Income Tax Assets, Net as first filed |
|---|---|---|
| 2026-06-30 | $911.80M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $1.10B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $1.14B 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $1.10B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $1.08B 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $1.03B 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $992.10M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $888.40M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $832.60M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $776.70M 10-Q · filed 2024-04-29 | |
| 2023-12-31 | $749.40M 10-K · filed 2025-02-28 | $754.60M 10-K · filed 2024-02-12 |
| 2023-09-30 | $651.90M 10-Q · filed 2023-10-27 | |
| 2023-06-30 | $610.70M 10-Q · filed 2023-07-28 | |
| 2023-03-31 | $544.00M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $484.00M 10-K · filed 2024-02-12 | |
| 2022-09-30 | $347.50M 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $307.60M 10-Q · filed 2022-07-29 | |
| 2022-03-31 | $294.90M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $246.70M 10-K · filed 2023-02-13 | |
| 2021-09-30 | $184.00M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $190.50M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $209.30M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $230.90M 10-K · filed 2022-02-14 | |
| 2020-09-30 | $215.20M 10-Q · filed 2020-10-26 | |
| 2020-06-30 | $204.10M 10-Q · filed 2020-07-27 | |
| 2020-03-31 | $158.00M 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $172.20M 10-K · filed 2021-02-12 | |
| 2019-09-30 | $155.80M 10-Q · filed 2019-10-25 | |
| 2019-06-30 | $163.80M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $164.50M 10-Q · filed 2019-04-26 | |
| 2018-12-31 | $174.00M 10-K · filed 2020-02-14 | |
| 2018-09-30 | $115.10M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $130.10M 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $181.40M 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $167.10M 10-K · filed 2019-02-15 | $213.60M 10-K · filed 2018-02-16 |
| 2017-09-30 | $197.10M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $185.20M 10-Q · filed 2017-07-28 | |
| 2016-12-31 | $203.80M 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |